A recent study reported that lncRNA CDKN2B-AS1/miR-141 axis could inhibit the migration, invasion and EMT process of ccRCC cells via reducing the expression of Cyclin D1 and Cyclin D2 [62]. Here, CCND1 is linked to nonpapillary renal cell carcinoma.